Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. (IMPACTS-2)
This study has been terminated.
( change in company plans )
Study NCT01522196   Information provided by Anthera Pharmaceuticals

First Received on January 18, 2012.   Last Updated on March 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Disease
Vaso-occlusive Crisis
Additional conditions recognized in this trial
Acute Chest Syndrome
Anemia, Sickle Cell
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Lung Diseases
Respiration Disorders
Respiratory Tract Diseases
Interventions listed in this trial
Varespladib
Placebo (Normal Saline)
Sponsors listed in this trial
Anthera Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services